Last reviewed · How we verify

NCT05435664

The Effect of Progressive Relaxation Exercise on Fatigue in Intensive Care Nurses

Completed NA Last updated 12 January 2024
What this trial tests

NA trial testing Progressive relaxation exercise in Intensive Care Nurse in 75 participants. Completed in 29 April 2022.

Timeline
1 April 2022
Primary endpoint
29 April 2022
29 April 2022

Quick facts

Lead sponsorMustafa Kemal University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment75
Start date1 April 2022
Primary completion29 April 2022
Estimated completion29 April 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mustafa Kemal University

Who can join

Adults 18 to 60, any sex, with Intensive Care Nurse or Fatigue. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study was planned as a randomized controlled experiment. It was aimed to examine the effect of progressive relaxation exercises applied to intensive care nurses on fatigue. The sociodemographic information of the participants will be collected with the 'Personal Information Form' and their fatigue levels with the 'Fatigue Severity Scale'. SPSS 22.0 package program will be used in the analysis of the data. p\<0.05 will be considered significant.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effect of progressive relaxation exercise on fatigue level of intensive care nurses: A randomised controlled trial.
    Askar Aşkar SE, Ovayolu OÖ, Ovayolu N. · · 2024 · cited 1× · PMID 38627114 · DOI 10.1016/j.aucc.2024.01.011

Verify or expand the search:

Other trials of Progressive relaxation exercise

Trials testing the same drug.

Other Mustafa Kemal University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05435664.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing